IL-23 promotes the development of castration-resistant prostate cancer

Immunol Cell Biol. 2018 Oct;96(9):883-885. doi: 10.1111/imcb.12195. Epub 2018 Sep 8.

Authors

Juming Yan^{1

2}, Daniel J Cua³, Michele Wl Teng^{1

2}

Affiliations

¹ Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
² School of Medicine, University of Queensland, Brisbane, Australia.
³ Merck Research Laboratories, Palo Alto, CA, USA.

PMID: 30194885
DOI: 10.1111/imcb.12195

No abstract available

Publication types

Comment

MeSH terms

Cell Line, Tumor
Humans
Interleukin-23
Male
Myeloid Cells
Prostatic Neoplasms*
Prostatic Neoplasms, Castration-Resistant*

Substances

Interleukin-23